Arterys, a San Francisco firm, won FDA clearance, following recent European CE Mark approval, to introduce its Arterys Cardio DL software that automates the process of segmenting ventricles on cardiac MRI imaging scans. Arterys claims that in a clinical setting the application is able to perform segmentation as accurately as experienced docs doing it manually, saving valuable time and letting physicians focus on less tedious tasks.
The software runs on the “cloud” provided by Arterys and essentially only requires images to be uploaded to the system. These can come from just about any MRI machine, since the software simply works with the image itself. It uses deep learning methodologies, run on powerful computers, that are based on thousands previously compiled and segmented cardiac MRI scans.
Here’s a short video, provided by Arterys, introducing the Cardio DL system: